Showing results (1271-1280 of 3,791) with videos related to
Sort By:
Pageof 380
Oncoimmunology|December 18, 2012
Targeting PD-1/PD-L1 interactions for cancer immunotherapyLaurence Zitvogel, Guido KroemerOncoimmunology|December 18, 2012
Role of the tumor suppressor ARF in macrophage polarization: Enhancement of the M2 phenotype in ARF-deficient miceSandra Herranz, Paqui G Través, Alfonso Luque, et al.Oncoimmunology|December 18, 2012
Functional differences between low- and high-affinity CD8(+) T cells in the tumor environmentRinke Bos, Kristi L Marquardt, Jocelyn Cheung, et al.Oncoimmunology|December 18, 2012
Depletion of phagocytic myeloid cells triggers spontaneous T cell- and NK cell-dependent antitumor activityAmanda M Guth, Scott D Hafeman, Steven W DowOncoimmunology|December 18, 2012
Characterization of T-cell responses against IκBα in cancer patientsShamaila Munir, Thomas Mørch Frøsig, Morten Hansen, et al.Oncoimmunology|December 18, 2012
Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcomaChristophe Paget, Helene Duret, Shin Foong Ngiow, et al.Oncoimmunology|December 18, 2012
NY-ESO-1 expression in sarcomas: A diagnostic marker and immunotherapy targetJin-Ping Lai, Avi Z Rosenberg, Markku M Miettinen, et al.Oncoimmunology|December 18, 2012
A new dynamic model of three cell interactions for CTL responsesKhawaja Ashfaque Ahmed, Lu Wang, Jim XiangOncoimmunology|December 18, 2012
Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growthTaku Fujimura, Yumi Kambayashi, Setsuya AibaOncoimmunology|December 18, 2012
Human Th17 cells in patients with cancer: Friends or foe?Tim F Greten, Fei Zhao, Jaba Gamrekelashvili, et al.Pageof 380